Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Positron-Emission Tomography”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT06443762
What this trial is testing

First Human Trial of Targeting MDM2/MDMX PET Imaging

Who this might be right for
MDM2/MDMX Gene MutationNuclear MedicinePositron Emission Tomography Imaing
Peking University Cancer Hospital & Institute 3
Very early researchEnded earlyNCT01105988
What this trial is testing

Evaluating Tumor Pseudoprogression With FLT-PET and MRI

Who this might be right for
Glioblastoma
Massachusetts General Hospital 2
Testing effectiveness (Phase 2)Study completedNCT05007548
What this trial is testing

To Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

Who this might be right for
Hepatic Carcinoma
National Atomic Research Institute, Taiwan 30
Not applicableNot Yet RecruitingNCT07747493
What this trial is testing

68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy

Who this might be right for
Prostate Cancer (Adenocarcinoma)Localized Prostate Cancer
University Health Network, Toronto 8
Not applicableNot Yet RecruitingNCT07510867
What this trial is testing

18F-FAPI PET/CT and MRI in Gastric Cancer

Who this might be right for
Gastric Cancer
First Affiliated Hospital of Zhejiang University 230
Not applicableStudy completedNCT01284829
What this trial is testing

Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study

Who this might be right for
Adrenal Tumors
Assistance Publique Hopitaux De Marseille 87
Testing effectiveness (Phase 2)Study completedNCT03278275
What this trial is testing

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Who this might be right for
Neuroendocrine Tumors
Rigshospitalet, Denmark 116
Testing effectiveness (Phase 2)WithdrawnNCT02424513
What this trial is testing

Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
ImaginAb, Inc.
Very early researchEnded earlyNCT03492164
What this trial is testing

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 6
Large-scale testing (Phase 3)WithdrawnNCT01961934
What this trial is testing

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Who this might be right for
Gliomas
Phoenix Molecular Imaging
Not applicableStudy completedNCT01081600
What this trial is testing

89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition

Who this might be right for
Breast Cancer
University Medical Center Groningen 7
Not applicableLooking for participantsNCT07302763
What this trial is testing

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Frederic Pouliot 45
Not applicableStudy completedNCT01880008
What this trial is testing

Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 5
Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Not applicableStudy completedNCT07833631
What this trial is testing

A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With Neuroblastoma

Who this might be right for
Neuroblastoma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) 43
Not applicableActive Not RecruitingNCT01582204
What this trial is testing

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cancer
Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00233974
What this trial is testing

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Not applicableStudy completedNCT05113576
What this trial is testing

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 132
Not applicableStudy completedNCT00139191
What this trial is testing

Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 20
Next Page